Error loading player: No playable sources found
NWFT08
The Current State of the 340B Program
Date
January 19, 2023
Explore related products in the following collection:
The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.
Speaker
Catherine Gilpin, CPA
Managing Director, FORVIS
Related Products
Medicare Cost Report
There are unique aspects to how health centers must bill and receive payment for the services they provide…
Introduction to Value Based Care
Change in anything is often met with trepidation but change often brings opportunities. During this session we will review the fundamentals of value based care and how it compares to the current reimbursement environment for FQHC’s…
CHC preparing for 2025
This session will address the current trends of health care and the issues that the CHC of 2025 may face…
Budgeting and Profitability
Health centers need to have positive bottom lines to fund growth and development. This session will show the link between budgeting and profitability and identify key drivers of the health center’s bottom line…
